DNDN
Dendreon Corporation
Biotechnology company developing immunotherapy for prostate cancer
CUSIP: 24823Q107HealthcareUS1 holder
Recent Activity
2014Q2
1 sell
-2.43M shares
-2.43M shares
Loading more activity...
Dendreon Corporation
Biotechnology company developing immunotherapy for prostate cancer